CRISPR

CRISPR2-il10ra

ID

ZDB-CRISPR-230622-4

Name

CRISPR2-il10ra

Previous Names

None

Target

il10ra (1)

Sequence

5' - GGTACGGGGGCTTCATTGGG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
psi71	il10ra

Expression

Gene expression in Wild Types + CRISPR2-il10ra

No data available

Phenotype

Phenotype resulting from CRISPR2-il10ra

No data available

Phenotype of all Fish created by or utilizing CRISPR2-il10ra

Phenotype	Fish	Conditions	Figures
neuromast macrophage il4r.1 expression increased amount, abnormal	il10ra^psi71/+; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
neuromast macrophage manf expression increased amount, abnormal	il10ra^psi71/+; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
macrophage interleukin-4-mediated signaling pathway increased efficacy, abnormal	il10ra^psi71/+; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
neuromast macrophage odc1 expression increased amount, abnormal	il10ra^psi71/+; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
macrophage polyamine biosynthetic process increased efficacy, abnormal	il10ra^psi71/+; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
neuromast macrophage il4r.1 expression increased amount, abnormal	il10ra^psi71/psi71; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
neuromast macrophage manf expression increased amount, abnormal	il10ra^psi71/psi71; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
macrophage interleukin-4-mediated signaling pathway increased efficacy, abnormal	il10ra^psi71/psi71; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
macrophage polyamine biosynthetic process increased efficacy, abnormal	il10ra^psi71/psi71; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
neuromast macrophage odc1 expression increased amount, abnormal	il10ra^psi71/psi71; gl22Tg	chemical treatment by environment: neomycin	Fig. 4 from Denans et al., 2022
neuromast hair cell synapse assembly decreased process quality, abnormal	il10ra^psi71/psi71; stat6^xt53/xt53	chemical treatment by environment: neomycin	Fig. 5 from Denans et al., 2022
neuromast macrophage Ab2-vamp2 labeling decreased amount, abnormal	il10ra^psi71/psi71; stat6^xt53/xt53	chemical treatment by environment: neomycin	Fig. 5 from Denans et al., 2022

Citations